The FINANCIAL -- Pfizer announced that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.

The FINANCIAL -- Pfizer announced the top-line primary endpoint result for Toviaz Study A0221049 – Efficacy and Safety of Fesoterodine Flexible Dose Regimen in Vulnerable Elderly Patients with Overactive Bladder.

The FINANCIAL -- The design of the study “Evaluation of the Impact of the Contour USB Blood Glucose Monitoring System with integrated Data Management on Glycemic Control in Insulin-treated Diabetic Patients”was presented by Professor Peter Schwarz, University of Dresden, Germany, at the World Diabetes Congress in Dubai.

The FINANCIAL -- Doctors are being urged to check the pulse of every patient they see. Research suggests that doing so could prevent 12,000 strokes a year, according to gulfnews.